Physician
Franciscan Physician Network
Franciscan Physician Network was paid $105.95M by Medicaid between Jan 2018 and Dec 2024, across 373 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoFRANCISCAN PHYSICIAN NETWORK
INDIANAPOLIS, IN 46237
INDIANAPOLIS, IN 46237
33aNPI1225327984assigned 04/04/2011
33bProvider typeInternal Medicine Physician
28Total paid$105.95M
24GClaims3,288,272
24DCodes billed373
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Indiana
Rank by total paid#3 of 316
Median peer was paid$17K
This provider vs. median6,263×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 522,978 | $7.74M | |
| 2019 | 421,189 | $16.85M | |
| 2020 | 336,291 | $12.61M | |
| 2021 | 375,802 | $17.18M | |
| 2022 | 382,953 | $17.91M | |
| 2023 | 743,489 | $19.30M | |
| 2024incomplete | 505,570 | $14.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 698,633 | 542,178 | $39.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 509,203 | 414,731 | $23.64M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.4% | 43,496 | 35,445 | $3.65M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.9% | 34,779 | 31,732 | $3.07M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.5% | 37,567 | 27,426 | $2.61M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.1% | 31,525 | 27,334 | $2.27M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.1% | 89,533 | 28,118 | $2.26M |
| 59425 | 2.1% | 34,831 | 25,223 | $2.18M | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.9% | 57,779 | 19,630 | $2.03M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.9% | 56,342 | 35,248 | $2.00M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.5% | 136,219 | 120,138 | $1.61M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 17,100 | 15,538 | $1.49M |
361 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.3% | 29,075 | $1.37M |
| 59426 | 1.1% | 18,739 | $1.22M | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.1% | 72,806 | $1.20M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 41,537 | $1.13M |
| 99223 | Prolong inpt eval add15 m | <1% | 13,641 | $925K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 10,698 | $915K |
| 90837 | Psychotherapy session, about an hour | <1% | 12,738 | $748K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 195,365 | $699K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 10,075 | $644K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 24,386 | $638K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 6,628 | $580K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 5,787 | $544K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 11,647 | $461K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 5,036 | $408K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 7,647 | $357K |
| 99205 | Prolong outpt/office vis | <1% | 5,751 | $348K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 5,071 | $324K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 12,121 | $293K |
| 76820 | <1% | 8,608 | $285K | |
| 99285 | Emergency room visit (most serious) | <1% | 4,966 | $274K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 358 | $258K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 4,242 | $224K |
| 99284 | Emergency room visit (serious) | <1% | 5,030 | $221K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 5,319 | $214K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 4,112 | $213K |
| 20610 | <1% | 7,807 | $207K | |
| 99283 | Emergency room visit (moderate) | <1% | 8,432 | $206K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 3,414 | $196K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 4,693 | $193K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 12,587 | $192K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 4,897 | $180K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12,830 | $179K |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | <1% | 335 | $151K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12,487 | $144K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,200 | $144K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 4,050 | $137K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,386 | $133K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 10,268 | $132K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 5,861 | $121K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 2,650 | $110K |
| 90474 | <1% | 8,214 | $105K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,761 | $100K |
| 99221 | <1% | 2,454 | $99K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,679 | $90K |
| 95806 | <1% | 2,599 | $86K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,811 | $85K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 16,434 | $82K |
| 99220 | <1% | 1,864 | $77K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,240 | $74K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 945 | $71K |
| 90686 | <1% | 34,304 | $68K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 911 | $58K |
| 94010 | <1% | 5,688 | $55K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 640 | $53K |
| 59430 | <1% | 1,437 | $53K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 829 | $44K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,656 | $42K |
| 90682 | <1% | 1,247 | $41K | |
| 59025 | Fetal non-stress test | <1% | 3,003 | $41K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 9,773 | $40K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 3,572 | $39K |
| 93000 | <1% | 6,706 | $37K | |
| 92015 | Determination of refractive state | <1% | 3,908 | $34K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 711 | $30K |
| 94729 | <1% | 4,866 | $29K | |
| 93295 | <1% | 1,722 | $29K | |
| 94726 | <1% | 4,187 | $27K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 8,180 | $27K |
| 11721 | <1% | 2,675 | $27K | |
| 31575 | <1% | 411 | $25K | |
| 94060 | <1% | 3,554 | $24K | |
| 99152 | <1% | 3,315 | $23K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,651 | $23K |
| 73630 | <1% | 1,988 | $22K | |
| 90670 | <1% | 15,961 | $22K | |
| 17110 | <1% | 682 | $22K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 153 | $22K |
| 36416 | <1% | 10,179 | $20K | |
| 73564 | <1% | 1,372 | $20K | |
| 91320 | <1% | 285 | $19K | |
| 90716 | <1% | 429 | $19K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 338 | $19K |
| 99460 | <1% | 282 | $17K | |
| 99385 | <1% | 948 | $17K | |
| 93016 | <1% | 2,436 | $17K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 915 | $17K |
| 73610 | <1% | 1,347 | $17K | |
| 95886 | <1% | 373 | $16K | |
| 99406 | <1% | 2,649 | $15K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,668 | $15K |
| 93294 | <1% | 2,349 | $15K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,365 | $15K |
| 90651 | <1% | 1,852 | $14K | |
| 90480 | <1% | 870 | $14K | |
| 46600 | <1% | 303 | $13K | |
| 99443 | <1% | 837 | $13K | |
| 99442 | <1% | 1,264 | $13K | |
| 99173 | <1% | 7,208 | $13K | |
| 92557 | <1% | 896 | $13K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 746 | $12K |
| 73030 | <1% | 1,403 | $12K | |
| 93018 | <1% | 2,616 | $12K | |
| 69210 | <1% | 818 | $12K | |
| 73562 | <1% | 2,356 | $11K | |
| 90715 | <1% | 2,732 | $11K | |
| 59514 | <1% | 410 | $11K | |
| 90961 | <1% | 949 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 366 | $11K |
| 98968 | <1% | 2,116 | $11K | |
| 90732 | <1% | 742 | $10K | |
| 87807 | <1% | 1,063 | $10K | |
| 99307 | <1% | 3,459 | $10K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 44 | $10K |
| 0001A | <1% | 556 | $9K | |
| 80305 | <1% | 962 | $9K | |
| 96127 | <1% | 2,634 | $9K | |
| 0071A | <1% | 450 | $9K | |
| 0003A | <1% | 397 | $9K | |
| 92567 | <1% | 1,530 | $8K | |
| 73110 | <1% | 723 | $8K | |
| 93458 | <1% | 226 | $8K | |
| 81002 | <1% | 6,715 | $8K | |
| 0124A | <1% | 340 | $7K | |
| 0072A | <1% | 205 | $7K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 45 | $7K |
| 99201 | <1% | 527 | $7K | |
| 90707 | <1% | 422 | $7K | |
| 95251 | <1% | 348 | $7K | |
| 97803 | <1% | 481 | $7K | |
| 90698 | <1% | 12,713 | $7K | |
| 99219 | <1% | 811 | $7K | |
| 82962 | <1% | 5,570 | $7K | |
| 76942 | <1% | 458 | $7K | |
| 62321 | <1% | 94 | $7K | |
| 90836 | <1% | 135 | $6K | |
| 81003 | <1% | 6,291 | $6K | |
| 11043 | <1% | 128 | $6K | |
| 99383 | <1% | 141 | $6K | |
| 93356 | <1% | 670 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,042 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,293 | $6K |
| 81025 | <1% | 2,404 | $5K | |
| 83655 | <1% | 428 | $5K | |
| 90656 | <1% | 1,749 | $5K | |
| 97802 | <1% | 97 | $5K | |
| 93454 | <1% | 42 | $5K | |
| 96156 | <1% | 123 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 667 | $5K |
| 93299 | <1% | 127 | $4K | |
| 99386 | <1% | 542 | $4K | |
| 99292 | <1% | 57 | $4K | |
| 98929 | <1% | 69 | $4K | |
| 99217 | <1% | 1,086 | $4K | |
| 64644 | <1% | 142 | $4K | |
| 90680 | <1% | 8,497 | $4K | |
| 99417 | Prolong home eval add 15m | <1% | 172 | $4K |
| 20611 | <1% | 102 | $4K | |
| 73130 | <1% | 528 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 119 | $4K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 915 | $4K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 50 | $4K |
| 95117 | <1% | 510 | $4K | |
| 62323 | <1% | 76 | $4K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 61 | $4K |
| 20550 | <1% | 374 | $3K | |
| 3044F | <1% | 12,456 | $3K | |
| 87430 | <1% | 448 | $3K | |
| 95811 | <1% | 182 | $3K | |
| 99305 | <1% | 301 | $3K | |
| 99401 | <1% | 292 | $3K | |
| 97162 | <1% | 212 | $3K | |
| 99382 | <1% | 49 | $3K | |
| V5266 | Battery for use in hearing device | <1% | 631 | $3K |
| 90671 | <1% | 4,911 | $3K | |
| 87081 | <1% | 424 | $3K | |
| 93227 | <1% | 562 | $3K | |
| 11104 | <1% | 33 | $3K | |
| 90739 | <1% | 21 | $3K | |
| 93296 | <1% | 378 | $2K | |
| 99407 | <1% | 327 | $2K | |
| 0002A | <1% | 120 | $2K | |
| 73560 | <1% | 394 | $2K | |
| 85018 | <1% | 961 | $2K | |
| 47562 | <1% | 246 | $2K | |
| 0154A | <1% | 57 | $2K | |
| 90620 | <1% | 305 | $2K | |
| 87400 | <1% | 448 | $2K | |
| 91322 | <1% | 39 | $2K | |
| 99441 | <1% | 279 | $2K | |
| 92083 | <1% | 95 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 681 | $2K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 128 | $2K |
| 90473 | <1% | 170 | $2K | |
| 43775 | <1% | 22 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 245 | $2K |
| 74018 | <1% | 147 | $2K | |
| 94375 | <1% | 336 | $2K | |
| 91321 | <1% | 25 | $2K | |
| 96133 | <1% | 18 | $2K | |
| 99381 | <1% | 103 | $2K | |
| 54150 | <1% | 27 | $2K | |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | <1% | 311 | $2K |
| 64493 | <1% | 12 | $1K | |
| 90734 | <1% | 1,689 | $1K | |
| 99225 | <1% | 764 | $1K | |
| 99459 | <1% | 110 | $1K | |
| 0081A | <1% | 63 | $1K | |
| 99226 | <1% | 399 | $1K | |
| 93272 | <1% | 146 | $1K | |
| 96132 | <1% | 17 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 579 | $1K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 120 | $1K |
| 0004A | <1% | 47 | $1K | |
| 91319 | <1% | 14 | $1K | |
| 0173A | <1% | 30 | $1K | |
| 90713 | <1% | 63 | $1K | |
| 96116 | <1% | 38 | $1K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 12 | $977.52 |
| 99354 | <1% | 90 | $958.64 | |
| 90632 | <1% | 109 | $926.67 | |
| 99497 | <1% | 461 | $911.38 | |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | <1% | 200 | $906.77 |
| 92551 | <1% | 115 | $904.58 | |
| 96161 | <1% | 569 | $892.46 | |
| 58571 | <1% | 101 | $852.80 | |
| 72100 | <1% | 146 | $810.14 | |
| 29075 | <1% | 45 | $793.76 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 119 | $792.82 |
| 91318 | <1% | 13 | $784.81 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 37 | $753.43 |
| 98927 | <1% | 13 | $664.04 | |
| 92587 | <1% | 62 | $661.43 | |
| 97161 | <1% | 145 | $659.03 | |
| 90744 | <1% | 2,783 | $632.00 | |
| 73140 | <1% | 163 | $611.10 | |
| 51798 | <1% | 131 | $605.63 | |
| 80061 | Lipid panel | <1% | 69 | $570.50 |
| 90633 | <1% | 4,691 | $560.79 | |
| 95012 | <1% | 136 | $553.20 | |
| 99304 | <1% | 22 | $544.78 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,003 | $519.02 |
| 0053A | <1% | 14 | $516.60 | |
| 90673 | <1% | 65 | $496.11 | |
| 58100 | <1% | 149 | $494.14 | |
| 76821 | <1% | 47 | $472.01 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 93 | $430.82 |
| 93298 | <1% | 53 | $425.31 | |
| 90746 | <1% | 206 | $413.88 | |
| 73502 | <1% | 339 | $375.69 | |
| 72050 | <1% | 33 | $373.25 | |
| 95816 | <1% | 18 | $310.98 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 51 | $295.82 |
| 73070 | <1% | 89 | $292.13 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 22 | $282.72 |
| 99218 | <1% | 202 | $280.41 | |
| 72110 | <1% | 153 | $279.54 | |
| 99384 | <1% | 16 | $276.61 | |
| 98967 | <1% | 77 | $270.18 | |
| 90962 | <1% | 21 | $267.70 | |
| 76937 | <1% | 32 | $263.37 | |
| 3046F | <1% | 85 | $260.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 76 | $245.08 |
| 90685 | <1% | 1,016 | $233.92 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 271 | $225.65 |
| 93880 | <1% | 18 | $215.63 | |
| 93325 | <1% | 548 | $203.82 | |
| 96381 | <1% | 13 | $203.25 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 53 | $194.98 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,070 | $188.73 |
| 76830 | Ultrasound, transvaginal | <1% | 152 | $171.10 |
| V5267 | Hearing aid or assistive listening device/supplies/accessories, not otherwise specified | <1% | 29 | $146.50 |
| 99318 | <1% | 16 | $138.78 | |
| 93320 | <1% | 284 | $134.98 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 697 | $128.13 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 340 | $123.02 |
| 93923 | <1% | 18 | $112.29 | |
| 11100 | <1% | 270 | $110.91 | |
| 20605 | <1% | 147 | $109.21 | |
| 90688 | <1% | 455 | $104.84 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,264 | $102.96 |
| 92283 | <1% | 12 | $100.90 | |
| 94664 | <1% | 22 | $97.46 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13 | $94.25 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 884 | $65.02 |
| 99174 | <1% | 15 | $56.32 | |
| 90672 | <1% | 179 | $55.44 | |
| 97035 | <1% | 192 | $51.96 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 100 | $35.97 |
| 72040 | <1% | 15 | $34.02 | |
| 73600 | <1% | 15 | $28.56 | |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 17 | $24.22 |
| 3074F | <1% | 130,782 | $15.00 | |
| 86580 | <1% | 199 | $12.48 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 218 | $12.26 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 98 | $11.86 |
| 93321 | <1% | 74 | $10.86 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 301 | $9.98 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 68 | $5.67 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 87 | $4.81 |
| 3060F | 0% | 1,973 | $0.00 | |
| 3008F | 0% | 265,901 | $0.00 | |
| 1111F | 0% | 8,197 | $0.00 | |
| 3079F | 0% | 30,211 | $0.00 | |
| 3075F | 0% | 6,414 | $0.00 | |
| 90619 | 0% | 419 | $0.00 | |
| 4010F | 0% | 12,469 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 453 | $0.00 |
| 90677 | 0% | 447 | $0.00 | |
| 90697 | 0% | 2,089 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 104 | $0.00 |
| 3351F | 0% | 1,177 | $0.00 | |
| 1125F | 0% | 65 | $0.00 | |
| 3352F | 0% | 125 | $0.00 | |
| 3353F | 0% | 268 | $0.00 | |
| 57454 | 0% | 83 | $0.00 | |
| 90696 | 0% | 235 | $0.00 | |
| 99462 | 0% | 21 | $0.00 | |
| 3080F | 0% | 134 | $0.00 | |
| 90381 | 0% | 33 | $0.00 | |
| 81001 | 0% | 112 | $0.00 | |
| 3048F | 0% | 143 | $0.00 | |
| 76801 | 0% | 12 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 78 | $0.00 |
| 90660 | 0% | 24 | $0.00 | |
| 99235 | 0% | 19 | $0.00 | |
| 64721 | 0% | 30 | $0.00 | |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 0% | 12 | $0.00 |
| 17000 | 0% | 17 | $0.00 | |
| 95911 | 0% | 16 | $0.00 | |
| 11730 | 0% | 16 | $0.00 | |
| 97597 | 0% | 18 | $0.00 | |
| 11200 | 0% | 15 | $0.00 | |
| 11900 | 0% | 15 | $0.00 | |
| 3078F | 0% | 99,376 | $0.00 | |
| 90710 | 0% | 693 | $0.00 | |
| 93350 | 0% | 215 | $0.00 | |
| 3077F | 0% | 1,144 | $0.00 | |
| 1160F | 0% | 31 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 33 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 143 | $0.00 |
| 90700 | 0% | 50 | $0.00 | |
| 27096 | 0% | 32 | $0.00 | |
| 93312 | 0% | 83 | $0.00 | |
| 20552 | 0% | 15 | $0.00 | |
| 90648 | 0% | 47 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 37 | $0.00 |
| 73565 | 0% | 53 | $0.00 | |
| 87210 | 0% | 176 | $0.00 | |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | 0% | 61 | $0.00 |
| 96101 | 0% | 32 | $0.00 | |
| 3051F | 0% | 13 | $0.00 | |
| 90681 | 0% | 14 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 65 | $0.00 |
| 10060 | 0% | 61 | $0.00 | |
| 1159F | 0% | 48 | $0.00 | |
| 93308 | 0% | 31 | $0.00 | |
| 82274 | 0% | 64 | $0.00 | |
| 11057 | 0% | 15 | $0.00 | |
| 17003 | 0% | 12 | $0.00 | |
| 27447 | 0% | 18 | $0.00 | |
| 73590 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPHALEN, DONNA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Franciscan Physician Network | Mishawaka, IN | $16.17M |
| Franciscan Health Indianapolis & Mooresville | Indianapolis, IN | $6.79M |
| Indiana Blood and Marrow Transplantation LLC | Indianapolis, IN | $55K |
| GLHS Anesthesia Group | Lafayette, IN | $26K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.